Picture of China Resources Pharmaceutical logo

3320 — China Resources Pharmaceutical News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareBalancedLarge CapContrarian

Brief: China Resources Pharmaceutical Group Ltd Says Fy Revenue For Dong-E-E-Jiao Rmb4.041 Bln

March 27 (Reuters) - China Resources Pharmaceutical
Group Ltd  3320.HK :
    * FY REVENUE FOR DONG-E-E-JIAO RMB4.041 BILLION VERSUS
RMB3.85
BILLION
    * FY NET PROFIT ATTRIBUTABLE RMB780 MILLION VERSUS RMB440.4
MILLION FOR DONG-E-E-JIAO CO., LTD.


Further company coverage:  3320.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on China Resources Pharmaceutical

See all news